Studies have shown that brain endothelial damage increases AD pathogenesis in the brain in certain genotype carriers [6], therefore, we hypothesized that peripheral circulating CD34+CD133+ EPCs may reduce AD risk in particular genotypes. The gene discussed is PROM1; the disease is Alzheimer disease.